Literature DB >> 24163050

Patient enrollment onto clinical trials: the role of physician knowledge.

Justin R Gregg1, Leora Horn, Mario A Davidson, Jill Gilbert.   

Abstract

Sixty-six attending physicians at academic medical centers completed a 43-question self-assessment evaluating communication skills, comfort with clinical trial enrollment, and knowledge of patient-related barriers to enrollment on clinical trials. Responses and demographic information were analyzed for trends and for association with estimated trial enrollment. Physician-described enrollment of patients onto trials varied widely, with estimated enrollment varying from less than 5 patients to well over 125 enrolled during the previous year. Participants perceived themselves to have excellent communication skills and were comfortable with the trial enrollment process, though did not consistently identify patient-related barriers to enrollment. Physician knowledge of clinical trials currently enrolling within their field was associated with increased patient enrollment on study (p = 0.03). Academic physicians expressed confidence in their skills related to clinical trial enrollment despite less than ideal reported enrollment. Knowledge of clinical trials currently enrolling within a physician's specialty was associated with estimated patient enrollment, and may represent a correctable barrier to trial enrollment.

Entities:  

Mesh:

Year:  2014        PMID: 24163050     DOI: 10.1007/s13187-013-0548-z

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  21 in total

1.  Increasing participation of physicians and patients from underrepresented racial and ethnic groups in National Cancer Institute-sponsored clinical trials.

Authors:  Michaele C Christian; Edward L Trimble
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-03       Impact factor: 4.254

2.  Provider roles in the recruitment of underrepresented populations to cancer clinical trials.

Authors:  Mollie W Howerton; M Chris Gibbons; Charles R Baffi; Tiffany L Gary; Gabriel Y Lai; Shari Bolen; Jon Tilburt; Teerath Peter Tanpitukpongse; Renee F Wilson; Neil R Powe; Eric B Bass; Jean G Ford
Journal:  Cancer       Date:  2007-02-01       Impact factor: 6.860

Review 3.  Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review.

Authors:  Jean G Ford; Mollie W Howerton; Gabriel Y Lai; Tiffany L Gary; Shari Bolen; M Chris Gibbons; Jon Tilburt; Charles Baffi; Teerath Peter Tanpitukpongse; Renee F Wilson; Neil R Powe; Eric B Bass
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

4.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

5.  Assessing the impact of protocol design changes on clinical trial performance.

Authors:  Kenneth A Getz; Julia Wenger; Rafael A Campo; Edward S Seguine; Kenneth I Kaitin
Journal:  Am J Ther       Date:  2008 Sep-Oct       Impact factor: 2.688

Review 6.  Barriers to participation in randomised controlled trials: a systematic review.

Authors:  S Ross; A Grant; C Counsell; W Gillespie; I Russell; R Prescott
Journal:  J Clin Epidemiol       Date:  1999-12       Impact factor: 6.437

7.  Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective.

Authors:  C K Daugherty
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

Review 8.  Accuracy of physician self-assessment compared with observed measures of competence: a systematic review.

Authors:  David A Davis; Paul E Mazmanian; Michael Fordis; R Van Harrison; Kevin E Thorpe; Laure Perrier
Journal:  JAMA       Date:  2006-09-06       Impact factor: 56.272

Review 9.  Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors.

Authors:  Edward J Mills; Dugald Seely; Beth Rachlis; Lauren Griffith; Ping Wu; Kumanan Wilson; Peter Ellis; James R Wright
Journal:  Lancet Oncol       Date:  2006-02       Impact factor: 41.316

10.  How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.

Authors:  Warren B Sateren; Edward L Trimble; Jeffrey Abrams; Otis Brawley; Nancy Breen; Leslie Ford; Mary McCabe; Richard Kaplan; Malcolm Smith; Richard Ungerleider; Michaele C Christian
Journal:  J Clin Oncol       Date:  2002-04-15       Impact factor: 44.544

View more
  1 in total

1.  Knowledge of Clinical Trial Availability and Reasons for Nonparticipation Among Adolescent and Young Adult Cancer Patients: A Population-based Study.

Authors:  Margarett Shnorhavorian; David R Doody; Vivien W Chen; Ann S Hamilton; Ikuko Kato; Rosemary D Cress; Michele West; Xiao-Cheng Wu; Theresa H M Keegan; Linda C Harlan; Stephen M Schwartz
Journal:  Am J Clin Oncol       Date:  2018-06       Impact factor: 2.339

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.